Gastrointestinal Stromal Tumors (GIST) Medications

Chemotherapy Medications Learn more >> More >>

DRUG	GENERIC NAME	DRUG INDICATION
Chemotherapy	Multiple	Cytotoxic chemotherapy, the oldest and most commonly used type of cancer treatment, halts cell division and kills rapidly growing cells. For a full list of chemotherapy drugs, click here.

Targeted Therapy Medications Learn more >> More >>

DRUG	GENERIC NAME	DRUG INDICATION
Ayvakit	avapritinib	Ayvakit is a kinase inhibitor approved for the treatment of inoperable or metastatic gastrointestinal stromal tumor (GIST) with specific PDGFRA mutations and for advanced systemic mastocytosis.
Gleevec	imatinib	Gleevec, a kinase inhibitor, was one of the first targeted therapies for cancer treatment. It is approved for many indications including Philadelphia chromosome positive (Ph+) chronic myeloid leukemia and acute lymphoblastic leukemia, chronic eosinophilic leukemia, mastocytosis and gastrointestinal stromal tumor.
Rozlytrek	entrectinib	Rozlytrek is approved for the treatment of solid tumors anywhere in the body that have NTRK gene fusions and for ROS1-positive non-small-cell lung cancer.
Stivarga	regorafenib	Stivarga is a multikinase inhibitor approved for metastatic colorectal cancer, advanced or metastatic gastrointestinal stromal tumor (GIST) and liver cancer previously treated with Nexavar (sorafenib).
Sutent	sunitib	Sutent is a kinase inhibitor approved for treatment of gastrointestinal stromal tumor, pancreatic neuroendocrine tumors and advanced kidney cancer (renal cell carcinoma), and for adjuvant treatment of high-risk kidney cancer after surgery.
Vitrakvi	larotrectinib	Vitrakvi is a TRK inhibitor that works against cancers anywhere in the body with NTRK gene fusions.

Chemotherapy Medications More >>

DRUG Chemotherapy
GENERIC NAME Multiple
DRUG INDICATION Cytotoxic chemotherapy, the oldest and most commonly used type of cancer treatment, halts cell division and kills rapidly growing cells. For a full list of chemotherapy drugs, click here.

Targeted Therapy Medications More >>

DRUG Ayvakit
GENERIC NAME avapritinib
DRUG INDICATION Ayvakit is a kinase inhibitor approved for the treatment of inoperable or metastatic gastrointestinal stromal tumor (GIST) with specific PDGFRA mutations and for advanced systemic mastocytosis.

DRUG Gleevec
GENERIC NAME imatinib
DRUG INDICATION Gleevec, a kinase inhibitor, was one of the first targeted therapies for cancer treatment. It is approved for many indications including Philadelphia chromosome positive (Ph+) chronic myeloid leukemia and acute lymphoblastic leukemia, chronic eosinophilic leukemia, mastocytosis and gastrointestinal stromal tumor.

DRUG Rozlytrek
GENERIC NAME entrectinib
DRUG INDICATION Rozlytrek is approved for the treatment of solid tumors anywhere in the body that have NTRK gene fusions and for ROS1-positive non-small-cell lung cancer.

DRUG Stivarga
GENERIC NAME regorafenib
DRUG INDICATION Stivarga is a multikinase inhibitor approved for metastatic colorectal cancer, advanced or metastatic gastrointestinal stromal tumor (GIST) and liver cancer previously treated with Nexavar (sorafenib).

DRUG Sutent
GENERIC NAME sunitib
DRUG INDICATION Sutent is a kinase inhibitor approved for treatment of gastrointestinal stromal tumor, pancreatic neuroendocrine tumors and advanced kidney cancer (renal cell carcinoma), and for adjuvant treatment of high-risk kidney cancer after surgery.

DRUG Vitrakvi
GENERIC NAME larotrectinib
DRUG INDICATION Vitrakvi is a TRK inhibitor that works against cancers anywhere in the body with NTRK gene fusions.